Activity Preview


An Update on Neurocognitive Disorders for the General Psychiatrist: An Approach to the Assessment and Management of Dementia in Psychiatric Practice

Activity Type:

  • On Demand

Release Date: 4/1/2016

Expiration Date: 4/1/2022

  • AMA PRA Category 1: 0.5
  • Participation: 0.5



Psychiatrists have an important role in the prevention, diagnosis and management of dementia. The psychiatric patient population is at high risk for the development of neurocognitive disorders. Individuals with bipolar disorder and schizophrenia present with cognitive dysfunction throughout the life span, and are at increased risk of cognitive decline as they age. Depression is also a known risk factor for dementia. This presentation aims to provide an evidence-based approach to the assessment of neurocognitive disorders in older adults in a general psychiatric practice and to the management of mild dementia. The use of appropriate tools for neuropsychological and functional assessment can help guide diagnosis and management strategies. There are many potentially reversible causes of cognitive impairment, including medications, medical illness and substance misuse, which can be considered and investigated. Most psychotropic medications, including antipsychotics, benzodiazepines, anticonvulsants, lithium, and antidepressants with anticholinergic properties, have significant effects on cognitive function. Dose adjustment or switching of these medications in older adults may help to optimize cognitive function. From the perspective of psychiatric management of mild dementia, the value of certain psychotherapies and the use of cholinesterase inhibitors will be explored.

**This content was captured at the 2015 APA Annual Meeting


  • General Member - $6.25
  • Resident-Fellow Member - Free
  • Medical Student Member - $6.25
  • Non-Member - $12.50

Free member registration for this course through the Course of the Month program ended on April 30th 

Educational Objectives

  • Describe the relationships between severe and persistent mental illness and dementia
  • List the impact of psychotropic medications on the cognitive functioning of older adults
  • Describe preventative and treatment interventions for dementia in psychiatric practice


Target Audience

Residents/Fellows, Psychiatrists

Estimated Time to Complete

Estimated Duration: 0.5 hours
Program Start: April 1, 2016 
Program End: April 1, 2022

How to Earn Credit

Participants who wish to earn AMA PRA Category 1 Credit ™ or a certificate of participation may do so by completing all sections of the course including the evaluation. A multiple choice quiz is provided based on the content. A passing score of 100% must be achieved. Retakes are available for the test. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the date of completion and hours earned. 

Continuing Education Credit

The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures


  • Andrea Iaboni, D.Phil., M.D., University of Toronto, Toronto Rehabilitation Institute. Reports no financial relationships with commercial interests.

Program Planners

  • Tristan Gorrindo, M.D., Director of Education, American Psychiatric Association. Reports no financial relationships with commercial interests
  • Jon Fanning, M.S., C.A.E., Chief of Membership and RFM-ECP, American Psychiatric Association. Reports no financial relationships with commercial interests
  • Stephanie Auditore, J.D., Director of Member Product Developmpent, Engagement & Portfolio Management, American Psychiatric Association. Reports no financial relationships with commercial interests
  • Ricardo A. Juarez, M.S., Associate Director, Office of International Affairs, American Psychiatric Association. Reports no financial relationships with commercial interests

Accessibility for Participants with Disabilities

The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of APA’s online resources, please contact us at 202-559-3900 for assistance.

Hardware/Software Requirements

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This website requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration

  • Flash Player: Adobe Flash Player 10.3+ 
  • Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
  • Operating System: Windows XP+ or Mac OS X 10.4+ 
  • Internet Connection: 1 Mbps or higher

Minimum Requirements

  • Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
  • Macintosh:Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content

For assistance: Contact for questions about this course | Contact for technical assistance